Pier Paolo Pandolfi

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Chemicals & Drugs

Disorders

Physiology

Anatomy

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Maeda Takahiro; Ito Keisuke; Merghoub Taha; Poliseno Laura; Hobbs Robin M; Wang Guocan; Dong Lin; Maeda Manami; Dore Louis C; Zelent Arthur; Luzzatto Lucio; Teruya-Feldstein Julie; Weiss Mitchell J; Pandolfi Pier Paolo
LRF is an essential downstream target of GATA1 in erythroid development and regulates BIM-dependent apoptosis.
Gewinner Christina; Wang Zhigang C; Richardson Andrea; Teruya-Feldstein Julie; Etemadmoghadam Dariush; Bowtell David; Barretina Jordi; Lin William M; Rameh Lucia; Salmena Leonardo; Pandolfi Pier Paolo; Cantley Lewis C
Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling.
Gutierrez Alejandro; Sanda Takaomi; Grebliunaite Ruta; Carracedo Arkaitz; Salmena Leonardo; Ahn Yebin; Dahlberg Suzanne; Neuberg Donna; Moreau Lisa A; Winter Stuart S; Larson Richard; Zhang Jianhua; Protopopov Alexei; Chin Lynda; Pandolfi Pier Paolo; Silverman Lewis B; Hunger Stephen P; Sallan Stephen E; Look A Thomas
High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Pier Paolo Pandolfi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Maeda Takahiro; Ito Keisuke; Merghoub Taha; Poliseno Laura; Hobbs Robin M; Wang Guocan; Dong Lin; Maeda Manami; Dore Louis C; Zelent Arthur; Luzzatto Lucio; Teruya-Feldstein Julie; Weiss Mitchell J; Pandolfi Pier Paolo
LRF is an essential downstream target of GATA1 in erythroid development and regulates BIM-dependent apoptosis.
Developmental cell 2009;17(4):527-40.
2009: Gewinner Christina; Wang Zhigang C; Richardson Andrea; Teruya-Feldstein Julie; Etemadmoghadam Dariush; Bowtell David; Barretina Jordi; Lin William M; Rameh Lucia; Salmena Leonardo; Pandolfi Pier Paolo; Cantley Lewis C
Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling.
Cancer cell 2009;16(2):115-25.
2009: Gutierrez Alejandro; Sanda Takaomi; Grebliunaite Ruta; Carracedo Arkaitz; Salmena Leonardo; Ahn Yebin; Dahlberg Suzanne; Neuberg Donna; Moreau Lisa A; Winter Stuart S; Larson Richard; Zhang Jianhua; Protopopov Alexei; Chin Lynda; Pandolfi Pier Paolo; Silverman Lewis B; Hunger Stephen P; Sallan Stephen E; Look A Thomas
High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia.
Blood 2009;114(3):647-50.
2009: Salazar María; Carracedo Arkaitz; Salanueva Iñigo J; Hernández-Tiedra Sonia; Lorente Mar; Egia Ainara; Vázquez Patricia; Blázquez Cristina; Torres Sofía; García Stephane; Nowak Jonathan; Fimia Gian María; Piacentini Mauro; Cecconi Francesco; Pandolfi Pier Paolo; González-Feria Luis; Iovanna Juan L; Guzmán Manuel; Boya Patricia; Velasco Guillermo
Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells.
The Journal of clinical investigation 2009;119(5):1359-72.
2009: Carver Brett S; Tran Jennifer; Gopalan Anuradha; Chen Zhenbang; Shaikh Safa; Carracedo Arkaitz; Alimonti Andrea; Nardella Caterina; Varmeh Shohreh; Scardino Peter T; Cordon-Cardo Carlos; Gerald William; Pandolfi Pier Paolo
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate.
Nature genetics 2009;41(5):619-24.
2009: Clohessy John G; Pandolfi Pier Paolo
beta-tting on p63 as a metastatic suppressor.
Cell 2009;137(1):28-30.
2009: Lin Hui-Kuan; Wang Guocan; Chen Zhenbang; Teruya-Feldstein Julie; Liu Yan; Chan Chia-Hsin; Yang Wei-Lei; Erdjument-Bromage Hediye; Nakayama Keiichi I; Nimer Stephen; Tempst Paul; Pandolfi Pier Paolo
Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKB.
Nature cell biology 2009;11(4):420-32.
2009: Ito Keisuke; Bernardi Rosa; Pandolfi Pier Paolo
A novel signaling network as a critical rheostat for the biology and maintenance of the normal stem cell and the cancer-initiating cell.
Current opinion in genetics & development 2009;19(1):51-9.
2009: Carver Brett S; Tran Jennifer; Chen Zhenbang; Carracedo-Perez Arkaitz; Alimonti Andrea; Nardella Caterina; Gopalan Anuradha; Scardino Peter T; Cordon-Cardo Carlos; Gerald William; Pandolfi Pier Paolo
ETS rearrangements and prostate cancer initiation.
Nature 2009;457(7231):E1; discussion E2-3.
2009: Li Li; Dutra Amalia; Pak Evgenia; Labrie Joseph E; Gerstein Rachel M; Pandolfi Pier Paolo; Recht Larry D; Ross Alonzo H
EGFRvIII expression and PTEN loss synergistically induce chromosomal instability and glial tumors.
Neuro-oncology 2009;11(1):9-21.
2009: Chen Zhenbang; Carracedo Arkaitz; Lin Hui-Kuan; Koutcher Jason A; Behrendt Nille; Egia Ainara; Alimonti Andrea; Carver Brett S; Gerald William; Teruya-Feldstein Julie; Loda Massimo; Pandolfi Pier Paolo
Differential p53-independent outcomes of p19(Arf) loss in oncogenesis.
Science signaling 2009;2(84):ra44.
2009: Nardella Caterina; Carracedo Arkaitz; Alimonti Andrea; Hobbs Robin M; Clohessy John G; Chen Zhenbang; Egia Ainara; Fornari Alessandro; Fiorentino Michelangelo; Loda Massimo; Kozma Sara C; Thomas George; Cordon-Cardo Carlos; Pandolfi Pier Paolo
Differential requirement of mTOR in postmitotic tissues and tumorigenesis.
Science signaling 2009;2(55):ra2.
2008: Carracedo Arkaitz; Baselga Jose; Pandolfi Pier Paolo
Deconstructing feedback-signaling networks to improve anticancer therapy with mTORC1 inhibitors.
Cell cycle (Georgetown, Tex.) 2008;7(24):3805-9.
2008: Nasr Rihab; Guillemin Marie-Claude; Ferhi Omar; Soilihi Hassan; Peres Laurent; Berthier Caroline; Rousselot Philippe; Robledo-Sarmiento Macarena; Lallemand-Breitenbach Valérie; Gourmel Bernard; Vitoux Dominique; Pandolfi Pier Paolo; Rochette-Egly Cécile; Zhu Jun; de Thé Hugues
Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation.
Nature medicine 2008;14(12):1333-42.
2008: Maggi Leonard B; Kuchenruether Michael; Dadey David Y A; Schwope Rachel M; Grisendi Silvia; Townsend R Reid; Pandolfi Pier Paolo; Weber Jason D
Nucleophosmin serves as a rate-limiting nuclear export chaperone for the Mammalian ribosome.
Molecular and cellular biology 2008;28(23):7050-65.
2008: Shima Yutaka; Shima Takito; Chiba Tomoki; Irimura Tatsuro; Pandolfi Pier Paolo; Kitabayashi Issay
PML activates transcription by protecting HIPK2 and p300 from SCFFbx3-mediated degradation.
Molecular and cellular biology 2008;28(23):7126-38.
2008: Bernardi R; Papa A; Pandolfi P P
Regulation of apoptosis by PML and the PML-NBs.
Oncogene 2008;27(48):6299-312.
2008: Song Min Sup; Salmena Leonardo; Carracedo Arkaitz; Egia Ainara; Lo-Coco Francesco; Teruya-Feldstein Julie; Pandolfi Pier Paolo
The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network.
Nature 2008;455(7214):813-7.
2008: Carracedo A; Pandolfi P P
The PTEN-PI3K pathway: of feedbacks and cross-talks.
Oncogene 2008;27(41):5527-41.
2008: Carracedo Arkaitz; Ma Li; Teruya-Feldstein Julie; Rojo Federico; Salmena Leonardo; Alimonti Andrea; Egia Ainara; Sasaki Atsuo T; Thomas George; Kozma Sara C; Papa Antonella; Nardella Caterina; Cantley Lewis C; Baselga Jose; Pandolfi Pier Paolo
Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer.
The Journal of clinical investigation 2008;118(9):3065-74.
2008: Kovalovsky Damian; Uche Olisambu U; Eladad Sonia; Hobbs Robin M; Yi Woelsung; Alonzo Eric; Chua Kevin; Eidson Maggie; Kim Hye-Jung; Im Jin S; Pandolfi Pier Paolo; Sant'Angelo Derek B
The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions.
Nature immunology 2008;9(9):1055-64.
2008: Hayakawa Fumihiko; Abe Akihiro; Kitabayashi Issay; Pandolfi Pier Paolo; Naoe Tomoki
Acetylation of PML is involved in histone deacetylase inhibitor-mediated apoptosis.
The Journal of biological chemistry 2008;283(36):24420-5.
2008: Nardella Caterina; Chen Zhenbang; Salmena Leonardo; Carracedo Arkaitz; Alimonti Andrea; Egia Ainara; Carver Brett; Gerald William; Cordon-Cardo Carlos; Pandolfi Pier Paolo
Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic events.
Genes & development 2008;22(16):2172-7.
2008: Chen Shuming; Ndhlovu Lishomwa C; Takahashi Takeshi; Takeda Kazuyoshi; Ikarashi Yoshinori; Kikuchi Toshiaki; Murata Kazuko; Pandolfi Pier Paolo; Riccardi Carlo; Ono Masao; Sugamura Kazuo; Ishii Naoto
Co-inhibitory roles for glucocorticoid-induced TNF receptor in CD1d-dependent natural killer T cells.
European journal of immunology 2008;38(8):2229-40.
2008: Ito Keisuke; Bernardi Rosa; Morotti Alessandro; Matsuoka Sahoko; Saglio Giuseppe; Ikeda Yasuo; Rosenblatt Jacalyn; Avigan David E; Teruya-Feldstein Julie; Pandolfi Pier Paolo
PML targeting eradicates quiescent leukaemia-initiating cells.
Nature 2008;453(7198):1072-8.
2008: Costoya J A; Hobbs R M; Pandolfi P P
Cyclin-dependent kinase antagonizes promyelocytic leukemia zinc-finger through phosphorylation.
Oncogene 2008;27(27):3789-96.
2008: Carracedo Arkaitz; Salmena Leonardo; Pandolfi Pier Paolo
SnapShot: PTEN signaling pathways.
Cell 2008;133(3):550.e1.
2008: Salmena Leonardo; Carracedo Arkaitz; Pandolfi Pier Paolo
Tenets of PTEN tumor suppression.
Cell 2008;133(3):403-14.
2008: Sportoletti Paolo; Grisendi Silvia; Majid Samia M; Cheng Ke; Clohessy John G; Viale Agnes; Teruya-Feldstein Julie; Pandolfi Pier Paolo
Npm1 is a haploinsufficient suppressor of myeloid and lymphoid malignancies in the mouse.
Blood 2008;111(7):3859-62.
2008: Hambardzumyan Dolores; Becher Oren J; Rosenblum Marc K; Pandolfi Pier Paolo; Manova-Todorova Katia; Holland Eric C
PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo.
Genes & development 2008;22(4):436-48.
2008: Klimek Virginia M; Fircanis Sophia; Maslak Peter; Guernah Ilhem; Baum Michael; Wu Nian; Panageas Katherine; Wright John J; Pandolfi Pier Paolo; Nimer Stephen D
Tolerability, pharmacodynamics, and pharmacokinetics studies of depsipeptide (romidepsin) in patients with acute myelogenous leukemia or advanced myelodysplastic syndromes.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(3):826-32.
2008: O'Keeffe Gerard W; Gutierrez Humberto; Pandolfi Pier Paolo; Riccardi Carlo; Davies Alun M
NGF-promoted axon growth and target innervation requires GITRL-GITR signaling.
Nature neuroscience 2008;11(2):135-42.
2008: Janas Michelle L; Hodson Daniel; Stamataki Zania; Hill Sue; Welch Katie; Gambardella Laure; Trotman Lloyd C; Pandolfi Pier Paolo; Vigorito Elena; Turner Martin
The effect of deleting p110delta on the phenotype and function of PTEN-deficient B cells.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(2):739-46.
2008: Poliseno Laura; Pitto Letizia; Simili Marcella; Mariani Laura; Riccardi Luisa; Ciucci Alessia; Rizzo Milena; Evangelista Monica; Mercatanti Alberto; Pandolfi Pier Paolo; Rainaldi Giuseppe
The proto-oncogene LRF is under post-transcriptional control of MiR-20a: implications for senescence.
PloS one 2008;3(7):e2542.
2007: Bernardi Rosa; Pandolfi Pier Paolo
Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies.
Nature reviews. Molecular cell biology 2007;8(12):1006-16.
2007: Guidez Fabien; Parks Sarah; Wong Henna; Jovanovic Jelena V; Mays Ashley; Gilkes Amanda F; Mills Kenneth I; Guillemin Marie-Claude; Hobbs Robin M; Pandolfi Pier Paolo; de Thé Hugues; Solomon Ellen; Grimwade David
RARalpha-PLZF overcomes PLZF-mediated repression of CRABPI, contributing to retinoid resistance in t(11;17) acute promyelocytic leukemia.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(47):18694-9.
2007: Cheng K; Grisendi S; Clohessy J G; Majid S; Bernardi R; Sportoletti P; Pandolfi P P
The leukemia-associated cytoplasmic nucleophosmin mutant is an oncogene with paradoxical functions: Arf inactivation and induction of cellular senescence.
Oncogene 2007;26(53):7391-400.
2007: Filipponi Doria; Hobbs Robin M; Ottolenghi Sergio; Rossi Pellegrino; Jannini Emmanuele A; Pandolfi Pier Paolo; Dolci Susanna
Repression of kit expression by Plzf in germ cells.
Molecular and cellular biology 2007;27(19):6770-81.
2007: Seandel Marco; James Daylon; Shmelkov Sergey V; Falciatori Ilaria; Kim Jiyeon; Chavala Sai; Scherr Douglas S; Zhang Fan; Torres Richard; Gale Nicholas W; Yancopoulos George D; Murphy Andrew; Valenzuela David M; Hobbs Robin M; Pandolfi Pier Paolo; Rafii Shahin
Generation of functional multipotent adult stem cells from GPR125+ germline progenitors.
Nature 2007;449(7160):346-50.
2007: Hermann Brian P; Sukhwani Meena; Lin Chih-Cheng; Sheng Yi; Tomko Jamie; Rodriguez Mario; Shuttleworth Jennifer J; McFarland David; Hobbs Robin M; Pandolfi Pier Paolo; Schatten Gerald P; Orwig Kyle E
Characterization, cryopreservation, and ablation of spermatogonial stem cells in adult rhesus macaques.
Stem cells (Dayton, Ohio) 2007;25(9):2330-8.
2007: Ma Li; Teruya-Feldstein Julie; Bonner Pauline; Bernardi Rosa; Franz David Neal; Witte David; Cordon-Cardo Carlos; Pandolfi Pier Paolo
Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer.
Cancer research 2007;67(15):7106-12.
2007: Yoshida Hitoshi; Ichikawa Hitoshi; Tagata Yusuke; Katsumoto Takuo; Ohnishi Kazunori; Akao Yukihiro; Naoe Tomoki; Pandolfi Pier Paolo; Kitabayashi Issay
PML-retinoic acid receptor alpha inhibits PML IV enhancement of PU.1-induced C/EBPepsilon expression in myeloid differentiation.
Molecular and cellular biology 2007;27(16):5819-34.
2007: Salmena Leonardo; Pandolfi Pier Paolo
Changing venues for tumour suppression: balancing destruction and localization by monoubiquitylation.
Nature reviews. Cancer 2007;7(6):409-13.
2007: Hernando Eva; Charytonowicz Elizabeth; Dudas Maria E; Menendez Silvia; Matushansky Igor; Mills Joslyn; Socci Nicholas D; Behrendt Nille; Ma Li; Maki Robert G; Pandolfi Pier Paolo; Cordon-Cardo Carlos
The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas.
Nature medicine 2007;13(6):748-53.
2007: Maeda Takahiro; Merghoub Taha; Hobbs Robin M; Dong Lin; Maeda Manami; Zakrzewski Johannes; van den Brink Marcel R M; Zelent Arthur; Shigematsu Hirokazu; Akashi Koichi; Teruya-Feldstein Julie; Cattoretti Giorgio; Pandolfi Pier Paolo
Regulation of B versus T lymphoid lineage fate decision by the proto-oncogene LRF.
Science (New York, N.Y.) 2007;316(5826):860-6.
2007: Shen Wen Hong; Balajee Adayabalam S; Wang Jianli; Wu Hong; Eng Charis; Pandolfi Pier Paolo; Yin Yuxin
Essential role for nuclear PTEN in maintaining chromosomal integrity.
Cell 2007;128(1):157-70.
2007: Trotman Lloyd C; Wang Xinjiang; Alimonti Andrea; Chen Zhenbang; Teruya-Feldstein Julie; Yang Haijuan; Pavletich Nikola P; Carver Brett S; Cordon-Cardo Carlos; Erdjument-Bromage Hediye; Tempst Paul; Chi Sung-Gil; Kim Hyo-Jong; Misteli Tom; Jiang Xuejun; Pandolfi Pier Paolo
Ubiquitination regulates PTEN nuclear import and tumor suppression.
Cell 2007;128(1):141-56.
2007: Wang Xinjiang; Trotman Lloyd C; Koppie Theresa; Alimonti Andrea; Chen Zhenbang; Gao Zhonghua; Wang Junru; Erdjument-Bromage Hediye; Tempst Paul; Cordon-Cardo Carlos; Pandolfi Pier Paolo; Jiang Xuejun
NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN.
Cell 2007;128(1):129-39.
2007: Scaglioni P P; Pandolfi P P
The theory of APL revisited.
Current topics in microbiology and immunology 2007;313():85-100.
2007: Pandolfi P P
APL as a paradigm in biomedical research: a journey toward the cure.
Current topics in microbiology and immunology 2007;313():1-2.
2006: Choi Youn-Hee; Bernardi Rosa; Pandolfi Pier Paolo; Benveniste Etty N
The promyelocytic leukemia protein functions as a negative regulator of IFN-gamma signaling.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(49):18715-20.
2006: Schefe Jan H; Menk Mario; Reinemund Jana; Effertz Karin; Hobbs Robin M; Pandolfi Pier Paolo; Ruiz Patricia; Unger Thomas; Funke-Kaiser Heiko
A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein.
Circulation research 2006;99(12):1355-66.
2006: Shen Tian Huai; Lin Hui-Kuan; Scaglioni Pier Paolo; Yung Thomas M; Pandolfi Pier Paolo
The mechanisms of PML-nuclear body formation.
Molecular cell 2006;24(3):331-9.
2006: Bergmann Stephan; Pandolfi Pier Paolo
Giving blood: a new role for CD40 in tumorigenesis.
The Journal of experimental medicine 2006;203(11):2409-12.
2006: Joe Yeonsoo; Jeong Jae-Hoon; Yang Shutong; Kang Hyeog; Motoyama Noburu; Pandolfi Pier Paolo; Chung Jay H; Kim Myung K
ATR, PML, and CHK2 play a role in arsenic trioxide-induced apoptosis.
The Journal of biological chemistry 2006;281(39):28764-71.
2006: Yang Shutong; Jeong Jae-Hoon; Brown Alexandra L; Lee Chang-Hun; Pandolfi Pier Paolo; Chung Jay H; Kim Myung K
Promyelocytic leukemia activates Chk2 by mediating Chk2 autophosphorylation.
The Journal of biological chemistry 2006;281(36):26645-54.
2006: Bernardi Rosa; Guernah Ilhem; Jin David; Grisendi Silvia; Alimonti Andrea; Teruya-Feldstein Julie; Cordon-Cardo Carlos; Simon M Celeste; Rafii Shahin; Pandolfi Pier Paolo
PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR.
Nature 2006;442(7104):779-85.
2006: Scaglioni Pier Paolo; Yung Thomas M; Cai Lu Fan; Erdjument-Bromage Hediye; Kaufman Andrew J; Singh Bhuvanesh; Teruya-Feldstein Julie; Tempst Paul; Pandolfi Pier Paolo
A CK2-dependent mechanism for degradation of the PML tumor suppressor.
Cell 2006;126(2):269-83.
2006: Grisendi Silvia; Mecucci Cristina; Falini Brunangelo; Pandolfi Pier Paolo
Nucleophosmin and cancer.
Nature reviews. Cancer 2006;6(7):493-505.
2006: Chen Mei-Ling; Xu Pei-Zhang; Peng Xiao-ding; Chen William S; Guzman Grace; Yang Ximing; Di Cristofano Antonio; Pandolfi Pier Paolo; Hay Nissim
The deficiency of Akt1 is sufficient to suppress tumor development in Pten+/- mice.
Genes & development 2006;20(12):1569-74.
2006: Bai Feng; Pei Xin-Hai; Pandolfi Pier Paolo; Xiong Yue
p18 Ink4c and Pten constrain a positive regulatory loop between cell growth and cell cycle control.
Molecular and cellular biology 2006;26(12):4564-76.
2006: Trotman Lloyd C; Alimonti Andrea; Scaglioni Pier Paolo; Koutcher Jason A; Cordon-Cardo Carlos; Pandolfi Pier Paolo
Identification of a tumour suppressor network opposing nuclear Akt function.
Nature 2006;441(7092):523-7.
2006: Matsushita Hiromichi; Scaglioni Pier Paolo; Bhaumik Mantu; Rego Eduardo M; Cai Lu Fan; Majid Samia M; Miyachi Hayato; Kakizuka Akira; Miller Wilson H; Pandolfi Pier Paolo
In vivo analysis of the role of aberrant histone deacetylase recruitment and RAR alpha blockade in the pathogenesis of acute promyelocytic leukemia.
The Journal of experimental medicine 2006;203(4):821-8.
2006: Kashiwada Masaki; Cattoretti Giorgio; McKeag Lisa; Rouse Todd; Showalter Brian M; Al-Alem Umaima; Niki Masaru; Pandolfi Pier Paolo; Field Elizabeth H; Rothman Paul B
Downstream of tyrosine kinases-1 and Src homology 2-containing inositol 5'-phosphatase are required for regulation of CD4+CD25+ T cell development.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(7):3958-65.
2006: Zhao Mingming; Janas Justyna A; Niki Masaru; Pandolfi Pier Paolo; Van Aelst Linda
Dok-1 independently attenuates Ras/mitogen-activated protein kinase and Src/c-myc pathways to inhibit platelet-derived growth factor-induced mitogenesis.
Molecular and cellular biology 2006;26(7):2479-89.
2006: Rego E M; Ruggero D; Tribioli C; Cattoretti G; Kogan S; Redner R L; Pandolfi P P
Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha.
Oncogene 2006;25(13):1974-9.
2006: Maslak P; Chanel S; Camacho L H; Soignet S; Pandolfi P P; Guernah I; Warrell R; Nimer S
Pilot study of combination transcriptional modulation therapy with sodium phenylbutyrate and 5-azacytidine in patients with acute myeloid leukemia or myelodysplastic syndrome.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(2):212-7.
2006: Shaffer David R; Pandolfi Pier Paolo
Breaking the rules of cancer.
Nature medicine 2006;12(1):14-5.
2006: Savoia Elena; Fantini Maria Pia; Pandolfi Pier Paolo; Dallolio Laura; Collina Natalina
Assessing the construct validity of the Italian version of the EQ-5D: preliminary results from a cross-sectional study in North Italy.
Health and quality of life outcomes 2006;4():47.
2006: Andrés Vicente; Gascón-Irún Marisol; Pandolfi Pier Paolo; González-Navarro Herminia
Atheroma development in apolipoprotein E-null mice is not affected by partial inactivation of PTEN.
Frontiers in bioscience : a journal and virtual library 2006;11():2739-45.
2005: Nacerddine Karim; Lehembre François; Bhaumik Mantu; Artus Jérôme; Cohen-Tannoudji Michel; Babinet Charles; Pandolfi Pier Paolo; Dejean Anne
The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice.
Developmental cell 2005;9(6):769-79.
2005: Wang Jian; Devgan Vikram; Corrado Marcella; Prabhu Nita S; El-Deiry Wafik S; Riccardi Carlo; Pandolfi Pier Paolo; Missero Caterina; Dotto G Paolo
Glucocorticoid-induced tumor necrosis factor receptor is a p21Cip1/WAF1 transcriptional target conferring resistance of keratinocytes to UV light-induced apoptosis.
The Journal of biological chemistry 2005;280(45):37725-31.
2005: Maeda Takahiro; Hobbs Robin M; Pandolfi Pier Paolo
The transcription factor Pokemon: a new key player in cancer pathogenesis.
Cancer research 2005;65(19):8575-8.
2005: Bernassola Francesca; Oberst Andrew; Melino Gerry; Pandolfi Pier Paolo
The promyelocytic leukaemia protein tumour suppressor functions as a transcriptional regulator of p63.
Oncogene 2005;24(46):6982-6.
2005: Grisendi Silvia; Bernardi Rosa; Rossi Marco; Cheng Ke; Khandker Luipa; Manova Katia; Pandolfi Pier Paolo
Role of nucleophosmin in embryonic development and tumorigenesis.
Nature 2005;437(7055):147-53.
2005: Lin Hui-Kuan; Bergmann Stephan; Pandolfi Pier Paolo
Deregulated TGF-beta signaling in leukemogenesis.
Oncogene 2005;24(37):5693-700.
2005: Chen Zhenbang; Trotman Lloyd C; Shaffer David; Lin Hui-Kuan; Dotan Zohar A; Niki Masaru; Koutcher Jason A; Scher Howard I; Ludwig Thomas; Gerald William; Cordon-Cardo Carlos; Pandolfi Pier Paolo
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis.
Nature 2005;436(7051):725-30.
2005: Ma Li; Teruya-Feldstein Julie; Behrendt Nille; Chen Zhenbang; Noda Tetsuo; Hino Okio; Cordon-Cardo Carlos; Pandolfi Pier Paolo
Genetic analysis of Pten and Tsc2 functional interactions in the mouse reveals asymmetrical haploinsufficiency in tumor suppression.
Genes & development 2005;19(15):1779-86.
2005: Barna Maria; Pandolfi Pier Paolo; Niswander Lee
Gli3 and Plzf cooperate in proximal limb patterning at early stages of limb development.
Nature 2005;436(7048):277-81.
2005: Xiao Andrew; Yin Chaoying; Yang Chunyu; Di Cristofano Antonio; Pandolfi Pier Paolo; Van Dyke Terry
Somatic induction of Pten loss in a preclinical astrocytoma model reveals major roles in disease progression and avenues for target discovery and validation.
Cancer research 2005;65(12):5172-80.
2005: Oberst Andrew; Rossi Mario; Salomoni Paolo; Pandolfi Pier Paolo; Oren Moshe; Melino Gerry; Bernassola Francesca
Regulation of the p73 protein stability and degradation.
Biochemical and biophysical research communications 2005;331(3):707-12.
2005: Salomoni Paolo; Bernardi Rosa; Bergmann Stephan; Changou Austin; Tuttle Sara; Pandolfi Pier Paolo
The promyelocytic leukemia protein PML regulates c-Jun function in response to DNA damage.
Blood 2005;105(9):3686-90.
2005: Hu Xiaoyi; Pandolfi Pier Paolo; Li Yi; Koutcher Jason A; Rosenblum Marc; Holland Eric C
mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma.
Neoplasia (New York, N.Y.) 2005;7(4):356-68.
2005: Ma Li; Chen Zhenbang; Erdjument-Bromage Hediye; Tempst Paul; Pandolfi Pier Paolo
Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis.
Cell 2005;121(2):179-93.
2005: Cairo Stefano; De Falco Francesca; Pizzo Mariateresa; Salomoni Paolo; Pandolfi Pier Paolo; Meroni Germana
PML interacts with Myc, and Myc target gene expression is altered in PML-null fibroblasts.
Oncogene 2005;24(13):2195-203.
2005: Oki Shinji; Limnander André; Yao Pin Mei; Niki Masaru; Pandolfi Pier Paolo; Rothman Paul B
Dok1 and SHIP act as negative regulators of v-Abl-induced pre-B cell transformation, proliferation and Ras/Erk activation.
Cell cycle (Georgetown, Tex.) 2005;4(2):310-4.
2005: Maeda Takahiro; Hobbs Robin M; Merghoub Taha; Guernah Ilhem; Zelent Arthur; Cordon-Cardo Carlos; Teruya-Feldstein Julie; Pandolfi Pier Paolo
Role of the proto-oncogene Pokemon in cellular transformation and ARF repression.
Nature 2005;433(7023):278-85.
2005: Grisendi Silvia; Pandolfi Pier Paolo
NPM mutations in acute myelogenous leukemia.
The New England journal of medicine 2005;352(3):291-2.
2005: Okabe Seiichi; Fukuda Seiji; Kim Young-June; Niki Masaru; Pelus Louis M; Ohyashiki Kazuma; Pandolfi Pier Paolo; Broxmeyer Hal E
Stromal cell-derived factor-1alpha/CXCL12-induced chemotaxis of T cells involves activation of the RasGAP-associated docking protein p62Dok-1.
Blood 2005;105(2):474-80.
2005: Nguyen Lan Anh; Pandolfi Pier Paolo; Aikawa Yukiko; Tagata Yusuke; Ohki Misao; Kitabayashi Issay
Physical and functional link of the leukemia-associated factors AML1 and PML.
Blood 2005;105(1):292-300.
2005: Grisendi S; Pandolfi P P
Two decades of cancer genetics: from specificity to pleiotropic networks.
Cold Spring Harbor symposia on quantitative biology 2005;70():83-91.
2004: Niki Masaru; Di Cristofano Antonio; Zhao Mingming; Honda Hiroaki; Hirai Hisamaru; Van Aelst Linda; Cordon-Cardo Carlos; Pandolfi Pier Paolo
Role of Dok-1 and Dok-2 in leukemia suppression.
The Journal of experimental medicine 2004;200(12):1689-95.
2004: Piazza Francesco; Costoya José A; Merghoub Taha; Hobbs Robin M; Pandolfi Pier Paolo
Disruption of PLZP in mice leads to increased T-lymphocyte proliferation, cytokine production, and altered hematopoietic stem cell homeostasis.
Molecular and cellular biology 2004;24(23):10456-69.
2004: Pandolfi Pier Paolo
Breast cancer--loss of PTEN predicts resistance to treatment.
The New England journal of medicine 2004;351(22):2337-8.
2004: Montanaro Lorenzo; Pandolfi Pier Paolo
Initiation of mRNA translation in oncogenesis: the role of eIF4E.
Cell cycle (Georgetown, Tex.) 2004;3(11):1387-9.
2004: Lin Hui-Kuan; Bergmann Stephan; Pandolfi Pier Paolo
Cytoplasmic PML function in TGF-beta signalling.
Nature 2004;431(7005):205-11.
2004: Engelhardt Othmar G; Sirma Hüseyin; Pandolfi Pier-Paolo; Haller Otto
Mx1 GTPase accumulates in distinct nuclear domains and inhibits influenza A virus in cells that lack promyelocytic leukaemia protein nuclear bodies.
The Journal of general virology 2004;85(Pt 8):2315-26.
2004: Ferri Anna L M; Cavallaro Maurizio; Braida Daniela; Di Cristofano Antonello; Canta Annalisa; Vezzani Annamaria; Ottolenghi Sergio; Pandolfi Pier Paolo; Sala Mariaelvina; DeBiasi Silvia; Nicolis Silvia K
Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain.
Development (Cambridge, England) 2004;131(15):3805-19.
2004: Muriglan Stephanie J; Ramirez-Montagut Teresa; Alpdogan Onder; Van Huystee Thomas W; Eng Jeffrey M; Hubbard Vanessa M; Kochman Adam A; Tjoe Kartono H; Riccardi Carlo; Pandolfi Pier Paolo; Sakaguchi Shimon; Houghton Alan N; Van Den Brink Marcel R M
GITR activation induces an opposite effect on alloreactive CD4(+) and CD8(+) T cells in graft-versus-host disease.
The Journal of experimental medicine 2004;200(2):149-57.
2004: Bernardi Rosa; Scaglioni Pier Paolo; Bergmann Stephan; Horn Henning F; Vousden Karen H; Pandolfi Pier Paolo
PML regulates p53 stability by sequestering Mdm2 to the nucleolus.
Nature cell biology 2004;6(7):665-72.
2004: Bernassola Francesca; Salomoni Paolo; Oberst Andrew; Di Como Charles J; Pagano Michele; Melino Gerry; Pandolfi Pier Paolo
Ubiquitin-dependent degradation of p73 is inhibited by PML.
The Journal of experimental medicine 2004;199(11):1545-57.
2004: Costoya José A; Hobbs Robin M; Barna Maria; Cattoretti Giorgio; Manova Katia; Sukhwani Meena; Orwig Kyle E; Wolgemuth Debra J; Pandolfi Pier Paolo
Essential role of Plzf in maintenance of spermatogonial stem cells.
Nature genetics 2004;36(6):653-9.
2004: Woodring Pamela J; Meisenhelder Jill; Johnson Sam A; Zhou Guo-Lei; Field Jeffrey; Shah Kavita; Bladt Friedhelm; Pawson Tony; Niki Masaru; Pandolfi Pier Paolo; Wang Jean Y J; Hunter Tony
c-Abl phosphorylates Dok1 to promote filopodia during cell spreading.
The Journal of cell biology 2004;165(4):493-503.
2004: Ruggero Davide; Montanaro Lorenzo; Ma Li; Xu Wei; Londei Paola; Cordon-Cardo Carlos; Pandolfi Pier Paolo
The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis.
Nature medicine 2004;10(5):484-6.
2004: Holland Eric C; Sonenberg Nahum; Pandolfi Pier Paolo; Thomas George
Signaling control of mRNA translation in cancer pathogenesis.
Oncogene 2004;23(18):3138-44.
2004: Pandolfi Pier Paolo
Aberrant mRNA translation in cancer pathogenesis: an old concept revisited comes finally of age.
Oncogene 2004;23(18):3134-7.
2004: Steffan Joan S; Agrawal Namita; Pallos Judit; Rockabrand Erica; Trotman Lloyd C; Slepko Natalia; Illes Katalin; Lukacsovich Tamas; Zhu Ya-Zhen; Cattaneo Elena; Pandolfi Pier Paolo; Thompson Leslie Michels; Marsh J Lawrence
SUMO modification of Huntingtin and Huntington's disease pathology.
Science (New York, N.Y.) 2004;304(5667):100-4.
2004: Piccolo Enza; Vignati Sara; Maffucci Tania; Innominato Pasquale F; Riley Andrew M; Potter Barry V L; Pandolfi Pier Paolo; Broggini Massimo; Iacobelli Stefano; Innocenti Paolo; Falasca Marco
Inositol pentakisphosphate promotes apoptosis through the PI 3-K/Akt pathway.
Oncogene 2004;23(9):1754-65.
2004: Gurrieri Carmela; Nafa Khedoudja; Merghoub Taha; Bernardi Rosa; Capodieci Paola; Biondi Andrea; Nimer Stephen; Douer Dan; Cordon-Cardo Carlos; Gallagher Robert; Pandolfi Pier Paolo
Mutations of the PML tumor suppressor gene in acute promyelocytic leukemia.
Blood 2004;103(6):2358-62.
2004: de Stanchina Elisa; Querido Emmanuelle; Narita Masako; Davuluri Ramana V; Pandolfi Pier Paolo; Ferbeyre Gerardo; Lowe Scott W
PML is a direct p53 target that modulates p53 effector functions.
Molecular cell 2004;13(4):523-35.
2004: Gurrieri Carmela; Capodieci Paola; Bernardi Rosa; Scaglioni Pier Paolo; Nafa Khedoudja; Rush Laura J; Verbel David A; Cordon-Cardo Carlos; Pandolfi Pier Paolo
Loss of the tumor suppressor PML in human cancers of multiple histologic origins.
Journal of the National Cancer Institute 2004;96(4):269-79.
2004: Sukhai Mahadeo A; Wu Xuemei; Xuan Yali; Zhang Tong; Reis Patricia P; Dubé Karina; Rego Eduardo M; Bhaumik Mantu; Bailey Denis J; Wells Richard A; Kamel-Reid Suzanne; Pandolfi Pier Paolo
Myeloid leukemia with promyelocytic features in transgenic mice expressing hCG-NuMA-RARalpha.
Oncogene 2004;23(3):665-78.
2004: Xu Zhi-Xiang; Zhao Rui-Xun; Ding Tian; Tran Thanh T; Zhang Wei; Pandolfi Pier Paolo; Chang Kun-Sang
Promyelocytic leukemia protein 4 induces apoptosis by inhibition of survivin expression.
The Journal of biological chemistry 2004;279(3):1838-44.
2003: Trotman Lloyd C; Niki Masaru; Dotan Zohar A; Koutcher Jason A; Di Cristofano Antonio; Xiao Andrew; Khoo Alan S; Roy-Burman Pradip; Greenberg Norman M; Van Dyke Terry; Cordon-Cardo Carlos; Pandolfi Pier Paolo
Pten dose dictates cancer progression in the prostate.
PLoS biology 2003;1(3):E59.
2003: Bernardi Rosa; Pandolfi Pier Paolo
Role of PML and the PML-nuclear body in the control of programmed cell death.
Oncogene 2003;22(56):9048-57.
2003: Scaglioni Pier Paolo; Pandolfi Pier Paolo
Medicine: taking apart a cancer protein.
Nature 2003;426(6966):512-3.
2003: Ruzinova Marianna B; Schoer Rebecca A; Gerald William; Egan James E; Pandolfi Pier Paolo; Rafii Shahin; Manova Katia; Mittal Vivek; Benezra Robert
Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors.
Cancer cell 2003;4(4):277-89.
2003: Louria-Hayon Igal; Grossman Tamar; Sionov Ronit Vogt; Alsheich Osnat; Pandolfi Pier Paolo; Haupt Ygal
The promyelocytic leukemia protein protects p53 from Mdm2-mediated inhibition and degradation.
The Journal of biological chemistry 2003;278(35):33134-41.
2003: Moe-Behrens Gerd H; Pandolfi Pier Paolo
Targeting aberrant transcriptional repression in acute myeloid leukemia.
Reviews in clinical and experimental hematology 2003;7(2):139-59.
2003: Chee Ana V; Lopez Pascal; Pandolfi Pier Paolo; Roizman Bernard
Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects.
Journal of virology 2003;77(12):7101-5.
2003: Wu Wen-Shu; Xu Zhi-Xiang; Hittelman Walter N; Salomoni Paolo; Pandolfi Pier Paolo; Chang Kun-Sang
Promyelocytic leukemia protein sensitizes tumor necrosis factor alpha-induced apoptosis by inhibiting the NF-kappaB survival pathway.
The Journal of biological chemistry 2003;278(14):12294-304.
2003: Ariumi Yasuo; Ego Takeshi; Kaida Atsushi; Matsumoto Mikiko; Pandolfi Pier Paolo; Shimotohno Kunitada
Distinct nuclear body components, PML and SMRT, regulate the trans-acting function of HTLV-1 Tax oncoprotein.
Oncogene 2003;22(11):1611-9.
2003: Ruggero Davide; Pandolfi Pier Paolo
Does the ribosome translate cancer?
Nature reviews. Cancer 2003;3(3):179-92.
2003: Berthoux Lionel; Towers Greg J; Gurer Cagan; Salomoni Paolo; Pandolfi Pier Paolo; Luban Jeremy
As(2)O(3) enhances retroviral reverse transcription and counteracts Ref1 antiviral activity.
Journal of virology 2003;77(5):3167-80.
2003: Trotman Lloyd C; Pandolfi Pier Paolo
PTEN and p53: who will get the upper hand?
Cancer cell 2003;3(2):97-9.
2003: Carneiro Carmen; Jiao Maria Socorro; Hu Ming; Shaffer David; Park Michele; Pandolfi Pier Paolo; Cordon-Cardo Carlos; Koff Andrew
p27 deficiency desensitizes Rb-/- cells to signals that trigger apoptosis during pituitary tumor development.
Oncogene 2003;22(3):361-9.
2003: Ruggero Davide; Grisendi Silvia; Piazza Francesco; Rego Eduardo; Mari Francesca; Rao Pulivarthi H; Cordon-Cardo Carlos; Pandolfi Pier Paolo
Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification.
Science (New York, N.Y.) 2003;299(5604):259-62.
2003: Bernardi Rosa; Pandolfi Pier Paolo
The nucleolus: at the stem of immortality.
Nature medicine 2003;9(1):24-5.
2002: Blondel Danielle; Regad Tarick; Poisson Nicolas; Pavie Benjamen; Harper Francis; Pandolfi Pier Paolo; De Thé Hugues; Chelbi-Alix Mounira K
Rabies virus P and small P products interact directly with PML and reorganize PML nuclear bodies.
Oncogene 2002;21(52):7957-70.
2002: Kandel Eugene S; Skeen Jennifer; Majewski Nathan; Di Cristofano Antonio; Pandolfi Pier Paolo; Feliciano Claudine S; Gartel Andrei; Hay Nissim
Activation of Akt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damage.
Molecular and cellular biology 2002;22(22):7831-41.
2002: Kurian Sobha; Hogan Thomas F; Bleigh Ona C; Dowdy Yvonne G; Merghoub Taha; Pandolfi Pier Paolo; Wenger Sharon L
Atypical t(15;17)(q13;q12) in a patient with all-trans retinoic acid refractory secondary acute promyelocytic leukemia: a case report and review of the literature.
Cancer genetics and cytogenetics 2002;138(2):143-8.
2002: Best Jennifer L; Ganiatsas Soula; Agarwal Sadhana; Changou Austin; Salomoni Paolo; Shirihai Orian; Meluh Pamela B; Pandolfi Pier Paolo; Zon Leonard I
SUMO-1 protease-1 regulates gene transcription through PML.
Molecular cell 2002;10(4):843-55.
2002: Barna Maria; Merghoub Taha; Costoya José A; Ruggero Davide; Branford Matthew; Bergia Anna; Samori Bruno; Pandolfi Pier Paolo
Plzf mediates transcriptional repression of HoxD gene expression through chromatin remodeling.
Developmental cell 2002;3(4):499-510.
2002: Lacorazza H Daniel; Miyazaki Yasushi; Di Cristofano Antonio; Deblasio Anthony; Hedvat Cyrus; Zhang Jin; Cordon-Cardo Carlos; Mao Shifeng; Pandolfi Pier Paolo; Nimer Stephen D
The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cells.
Immunity 2002;17(4):437-49.
2002: Kim Sunghoon; Domon-Dell Claire; Wang Qingding; Chung Dai H; Di Cristofano Antonio; Pandolfi Pier Paolo; Freund Jean-Noel; Evers B Mark
PTEN and TNF-alpha regulation of the intestinal-specific Cdx-2 homeobox gene through a PI3K, PKB/Akt, and NF-kappaB-dependent pathway.
Gastroenterology 2002;123(4):1163-78.
2002: Longo Letizia; Vanegas Olga Camacho; Patel Meghavi; Rosti Vittorio; Li Haiqing; Waka John; Merghoub Taha; Pandolfi Pier Paolo; Notaro Rosario; Manova Katia; Luzzatto Lucio
Maternally transmitted severe glucose 6-phosphate dehydrogenase deficiency is an embryonic lethal.
The EMBO journal 2002;21(16):4229-39.
2002: Rego Eduardo M; Pandolfi Pier Paolo
Reciprocal products of chromosomal translocations in human cancer pathogenesis: key players or innocent bystanders?
Trends in molecular medicine 2002;8(8):396-405.
2002: Urnov Fyodor D; Rebar Edward J; Reik Andreas; Pandolfi Pier Paolo
Designed transcription factors as structural, functional and therapeutic probes of chromatin in vivo. Fourth in review series on chromatin dynamics.
EMBO reports 2002;3(7):610-5.
2002: Linggi Bryan; Müller-Tidow Carsten; van de Locht Louis; Hu Ming; Nip John; Serve Hubert; Berdel Wolfgang E; van der Reijden Bert; Quelle Dawn E; Rowley Janet D; Cleveland John; Jansen Joop H; Pandolfi Pier Paolo; Hiebert Scott W
The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia.
Nature medicine 2002;8(7):743-50.
2002: Rasheed Zeshaan A; Saleem Ahamed; Ravee Yaniv; Pandolfi Pier Paolo; Rubin Eric H
The topoisomerase I-binding RING protein, topors, is associated with promyelocytic leukemia nuclear bodies.
Experimental cell research 2002;277(2):152-60.
2002: Ronchetti Simona; Nocentini Giuseppe; Riccardi Carlo; Pandolfi Pier Paolo
Role of GITR in activation response of T lymphocytes.
Blood 2002;100(1):350-2.
2002: Kogan Scott C; Ward Jerrold M; Anver Miriam R; Berman Jules J; Brayton Cory; Cardiff Robert D; Carter John S; de Coronado Sherri; Downing James R; Fredrickson Torgny N; Haines Diana C; Harris Alan W; Harris Nancy Lee; Hiai Hiroshi; Jaffe Elaine S; MacLennan Ian C M; Pandolfi Pier Paolo; Pattengale Paul K; Perkins Archibald S; Simpson R Mark; Tuttle Mark S; Wong Joanne F; Morse Herbert C;
Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice.
Blood 2002;100(1):238-45.
2002: Morgan Michael; Thorburn Jacqueline; Pandolfi Pier Paolo; Thorburn Andrew
Nuclear and cytoplasmic shuttling of TRADD induces apoptosis via different mechanisms.
The Journal of cell biology 2002;157(6):975-84.
2002: Salomoni Paolo; Pandolfi Pier Paolo
p53 De-ubiquitination: at the edge between life and death.
Nature cell biology 2002;4(6):E152-3.
2002: Li Li; Liu Fenghua; Salmonsen Rebecca A; Turner Tod K; Litofsky N Scott; Di Cristofano Antonio; Pandolfi Pier Paolo; Jones Stephen N; Recht Larry D; Ross Alonzo H
PTEN in neural precursor cells: regulation of migration, apoptosis, and proliferation.
Molecular and cellular neurosciences 2002;20(1):21-9.
2002: Bernardi Rosa; Grisendi Silvia; Pandolfi Pier Paolo
Modelling haematopoietic malignancies in the mouse and therapeutical implications.
Oncogene 2002;21(21):3445-58.
2002: Ott Vanessa L; Tamir Idan; Niki Masaru; Pandolfi Pier Paolo; Cambier John C
Downstream of kinase, p62(dok), is a mediator of Fc gamma IIB inhibition of Fc epsilon RI signaling.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(9):4430-9.
2002: Xiao Andrew; Wu Hua; Pandolfi Pier Paolo; Louis David N; Van Dyke Terry
Astrocyte inactivation of the pRb pathway predisposes mice to malignant astrocytoma development that is accelerated by PTEN mutation.
Cancer cell 2002;1(2):157-68.
2002: Salomoni Paolo; Pandolfi Pier Paolo
The role of PML in tumor suppression.
Cell 2002;108(2):165-70.
2001: Ward J O; McConnell M J; Carlile G W; Pandolfi P P; Licht J D; Freedman L P
The acute promyelocytic leukemia-associated protein, promyelocytic leukemia zinc finger, regulates 1,25-dihydroxyvitamin D(3)-induced monocytic differentiation of U937 cells through a physical interaction with vitamin D(3) receptor.
Blood 2001;98(12):3290-300.
2001: He L Z; Tolentino T; Grayson P; Zhong S; Warrell R P; Rifkind R A; Marks P A; Richon V M; Pandolfi P P
Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia.
The Journal of clinical investigation 2001;108(9):1321-30.
2001: Piazza F; Gurrieri C; Pandolfi P P
The theory of APL.
Oncogene 2001;20(49):7216-22.
2001: Pandolfi P P
In vivo analysis of the molecular genetics of acute promyelocytic leukemia.
Oncogene 2001;20(40):5726-35.
2001: Keller P; Payne J L; Tremml G; Greer P A; Gaboli M; Pandolfi P P; Bessler M
FES-Cre targets phosphatidylinositol glycan class A (PIGA) inactivation to hematopoietic stem cells in the bone marrow.
The Journal of experimental medicine 2001;194(5):581-9.
2001: Pandolfi P P
Histone deacetylases and transcriptional therapy with their inhibitors.
Cancer chemotherapy and pharmacology 2001;48 Suppl 1():S17-9.
2001: Di Cristofano A; Niki M; Zhao M; Karnell F G; Clarkson B; Pear W S; Van Aelst L; Pandolfi P P
p62(dok), a negative regulator of Ras and mitogen-activated protein kinase (MAPK) activity, opposes leukemogenesis by p210(bcr-abl).
The Journal of experimental medicine 2001;194(3):275-84.
2001: Zhao M; Schmitz A A; Qin Y; Di Cristofano A; Pandolfi P P; Van Aelst L
Phosphoinositide 3-kinase-dependent membrane recruitment of p62(dok) is essential for its negative effect on mitogen-activated protein (MAP) kinase activation.
The Journal of experimental medicine 2001;194(3):265-74.
2001: Costoya J A; Pandolfi P P
The role of promyelocytic leukemia zinc finger and promyelocytic leukemia in leukemogenesis and development.
Current opinion in hematology 2001;8(4):212-7.
2001: Gaboli M; Kotsi P A; Gurrieri C; Cattoretti G; Ronchetti S; Cordon-Cardo C; Broxmeyer H E; Hromas R; Pandolfi P P
Mzf1 controls cell proliferation and tumorigenesis.
Genes & development 2001;15(13):1625-30.
2001: Regad T; Saib A; Lallemand-Breitenbach V; Pandolfi P P; de Thé H; Chelbi-Alix M K
PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator.
The EMBO journal 2001;20(13):3495-505.
2001: Lallemand-Breitenbach V; Zhu J; Puvion F; Koken M; Honoré N; Doubeikovsky A; Duprez E; Pandolfi P P; Puvion E; Freemont P; de Thé H
Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation.
The Journal of experimental medicine 2001;193(12):1361-71.
2001: Hu P; Beresten S F; van Brabant A J; Ye T Z; Pandolfi P P; Johnson F B; Guarente L; Ellis N A
Evidence for BLM and Topoisomerase IIIalpha interaction in genomic stability.
Human molecular genetics 2001;10(12):1287-98.
2001: Liao C; Wang X Y; Wei H Q; Li S Q; Merghoub T; Pandolfi P P; Wolgemuth D J
Altered myelopoiesis and the development of acute myeloid leukemia in transgenic mice overexpressing cyclin A1.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(12):6853-8.
2001: Pandolfi P P
Transcription therapy for cancer.
Oncogene 2001;20(24):3116-27.
2001: Pandolfi P P
Oncogenes and tumor suppressors in the molecular pathogenesis of acute promyelocytic leukemia.
Human molecular genetics 2001;10(7):769-75.
2001: Rego E M; Wang Z G; Peruzzi D; He L Z; Cordon-Cardo C; Pandolfi P P
Role of promyelocytic leukemia (PML) protein in tumor suppression.
The Journal of experimental medicine 2001;193(4):521-29.
2001: Di Cristofano A; De Acetis M; Koff A; Cordon-Cardo C; Pandolfi P P
Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse.
Nature genetics 2001;27(2):222-4.
2001: Merghoub T; Gurrieri C; Piazza F; Pandolfi P P
Modeling acute promyelocytic leukemia in the mouse: new insights in the pathogenesis of human leukemias.
Blood cells, molecules & diseases 2001;27(1):231-48.
2001: Lehembre F; Müller S; Pandolfi P P; Dejean A
Regulation of Pax3 transcriptional activity by SUMO-1-modified PML.
Oncogene 2001;20(1):1-9.
2001: Rego E M; Pandolfi P P
Analysis of the molecular genetics of acute promyelocytic leukemia in mouse models.
Seminars in hematology 2001;38(1):54-70.
2000: He L Z; Bhaumik M; Tribioli C; Rego E M; Ivins S; Zelent A; Pandolfi P P
Two critical hits for promyelocytic leukemia.
Molecular cell 2000;6(5):1131-41.
2000: Guo A; Salomoni P; Luo J; Shih A; Zhong S; Gu W; Pandolfi P P
The function of PML in p53-dependent apoptosis.
Nature cell biology 2000;2(10):730-6.
2000: Toney L M; Cattoretti G; Graf J A; Merghoub T; Pandolfi P P; Dalla-Favera R; Ye B H; Dent A L
BCL-6 regulates chemokine gene transcription in macrophages.
Nature immunology 2000;1(3):214-20.
2000: Ruggero D; Wang Z G; Pandolfi P P
The puzzling multiple lives of PML and its role in the genesis of cancer.
BioEssays : news and reviews in molecular, cellular and developmental biology 2000;22(9):827-35.
2000: Rego E M; He L Z; Warrell R P; Wang Z G; Pandolfi P P
Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(18):10173-8.
2000: Barna M; Hawe N; Niswander L; Pandolfi P P
Plzf regulates limb and axial skeletal patterning.
Nature genetics 2000;25(2):166-72.
2000: Zhong S; Salomoni P; Pandolfi P P
The transcriptional role of PML and the nuclear body.
Nature cell biology 2000;2(5):E85-90.
2000: Zhong S; Müller S; Ronchetti S; Freemont P S; Dejean A; Pandolfi P P
Role of SUMO-1-modified PML in nuclear body formation.
Blood 2000;95(9):2748-52.
2000: Di Cristofano A; Pandolfi P P
The multiple roles of PTEN in tumor suppression.
Cell 2000;100(4):387-90.
2000: Zhong S; Salomoni P; Ronchetti S; Guo A; Ruggero D; Pandolfi P P
Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis.
The Journal of experimental medicine 2000;191(4):631-40.
1999: Zhong S; Hu P; Ye T Z; Stan R; Ellis N A; Pandolfi P P
A role for PML and the nuclear body in genomic stability.
Oncogene 1999;18(56):7941-7.
1999: Zhong S; Delva L; Rachez C; Cenciarelli C; Gandini D; Zhang H; Kalantry S; Freedman L P; Pandolfi P P
A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins.
Nature genetics 1999;23(3):287-95.
1999: Tremml G; Dominguez C; Rosti V; Zhang Z; Pandolfi P P; Keller P; Bessler M
Increased sensitivity to complement and a decreased red blood cell life span in mice mosaic for a nonfunctional Piga gene.
Blood 1999;94(9):2945-54.
1999: Lee J O; Yang H; Georgescu M M; Di Cristofano A; Maehama T; Shi Y; Dixon J E; Pandolfi P; Pavletich N P
Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association.
Cell 1999;99(3):323-34.
1999: Harris M B; Chang C C; Berton M T; Danial N N; Zhang J; Kuehner D; Ye B H; Kvatyuk M; Pandolfi P P; Cattoretti G; Dalla-Favera R; Rothman P B
Transcriptional repression of Stat6-dependent interleukin-4-induced genes by BCL-6: specific regulation of iepsilon transcription and immunoglobulin E switching.
Molecular and cellular biology 1999;19(10):7264-75.
1999: He L Z; Merghoub T; Pandolfi P P
In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implications.
Oncogene 1999;18(38):5278-92.
1999: Di Cristofano A; Kotsi P; Peng Y F; Cordon-Cardo C; Elkon K B; Pandolfi P P
Impaired Fas response and autoimmunity in Pten+/- mice.
Science (New York, N.Y.) 1999;285(5436):2122-5.
1998: Warrell R P; He L Z; Richon V; Calleja E; Pandolfi P P
Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase.
Journal of the National Cancer Institute 1998;90(21):1621-5.
1998: Wang Z G; Ruggero D; Ronchetti S; Zhong S; Gaboli M; Rivi R; Pandolfi P P
PML is essential for multiple apoptotic pathways.
Nature genetics 1998;20(3):266-72.
1998: Soignet S L; Maslak P; Wang Z G; Jhanwar S; Calleja E; Dardashti L J; Corso D; DeBlasio A; Gabrilove J; Scheinberg D A; Pandolfi P P; Warrell R P
Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide.
The New England journal of medicine 1998;339(19):1341-8.
1998: Wang Z G; Rivi R; Delva L; König A; Scheinberg D A; Gambacorti-Passerini C; Gabrilove J L; Warrell R P; Pandolfi P P
Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARalpha independent manner.
Blood 1998;92(5):1497-504.
1998: Di Cristofano A; Pesce B; Cordon-Cardo C; Pandolfi P P
Pten is essential for embryonic development and tumour suppression.
Nature genetics 1998;19(4):348-55.
1998: Gaboli M; Gandini D; Delva L; Wang Z G; Pandolfi P P
Acute promyelocytic leukemia as a model for cross-talk between interferon and retinoic acid pathways: from molecular biology to clinical applications.
Leukemia & lymphoma 1998;30(1-2):11-22.
1998: Pandolfi P P
Knocking in and out genes and trans genes: the use of the engineered mouse to study normal and aberrant hemopoiesis.
Seminars in hematology 1998;35(2):136-48.
1998: Wang Z G; Delva L; Gaboli M; Rivi R; Giorgio M; Cordon-Cardo C; Grosveld F; Pandolfi P P
Role of PML in cell growth and the retinoic acid pathway.
Science (New York, N.Y.) 1998;279(5356):1547-51.
1998: Di Cristofano A; Carpino N; Dunant N; Friedland G; Kobayashi R; Strife A; Wisniewski D; Clarkson B; Pandolfi P P; Resh M D
Molecular cloning and characterization of p56dok-2 defines a new family of RasGAP-binding proteins.
The Journal of biological chemistry 1998;273(9):4827-30.
1998: He L Z; Guidez F; Tribioli C; Peruzzi D; Ruthardt M; Zelent A; Pandolfi P P
Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.
Nature genetics 1998;18(2):126-35.
1997: Kalantry S; Delva L; Gaboli M; Gandini D; Giorgio M; Hawe N; He L Z; Peruzzi D; Rivi R; Tribioli C; Wang Z G; Zhang H; Pandolfi P P
Gene rearrangements in the molecular pathogenesis of acute promyelocytic leukemia.
Journal of cellular physiology 1997;173(2):288-96.
1997: Longo L; Bygrave A; Grosveld F G; Pandolfi P P
The chromosome make-up of mouse embryonic stem cells is predictive of somatic and germ cell chimaerism.
Transgenic research 1997;6(5):321-8.
1997: Rosti V; Tremml G; Soares V; Pandolfi P P; Luzzatto L; Bessler M
Murine embryonic stem cells without pig-a gene activity are competent for hematopoiesis with the PNH phenotype but not for clonal expansion.
The Journal of clinical investigation 1997;100(5):1028-36.
1997: König A; Wrazel L; Warrell R P; Rivi R; Pandolfi P P; Jakubowski A; Gabrilove J L
Comparative activity of melarsoprol and arsenic trioxide in chronic B-cell leukemia lines.
Blood 1997;90(2):562-70.
1997: Ye B H; Cattoretti G; Shen Q; Zhang J; Hawe N; de Waard R; Leung C; Nouri-Shirazi M; Orazi A; Chaganti R S; Rothman P; Stall A M; Pandolfi P P; Dalla-Favera R
The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation.
Nature genetics 1997;16(2):161-70.
1997: He L Z; Tribioli C; Rivi R; Peruzzi D; Pelicci P G; Soares V; Cattoretti G; Pandolfi P P
Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(10):5302-7.
1996: Nason-Burchenal K; Gandini D; Botto M; Allopenna J; Seale J R; Cross N C; Goldman J M; Dmitrovsky E; Pandolfi P P
Interferon augments PML and PML/RAR alpha expression in normal myeloid and acute promyelocytic cells and cooperates with all-trans retinoic acid to induce maturation of a retinoid-resistant promyelocytic cell line.
Blood 1996;88(10):3926-36.
1996: Seale J R; Varma S; Swirsky D M; Pandolfi P P; Goldman J M; Cross N C
Quantification of PML-RAR alpha transcripts in acute promyelocytic leukaemia: explanation for the lack of sensitivity of RT-PCR for the detection of minimal residual disease and induction of the leukaemia-specific mRNA by alpha interferon.
British journal of haematology 1996;95(1):95-101.
1996: Pandolfi P P
PML, PLZF and NPM genes in the molecular pathogenesis of acute promyelocytic leukemia.
Haematologica 1996;81(5):472-82.
1996: Pelicci G; Dente L; De Giuseppe A; Verducci-Galletti B; Giuli S; Mele S; Vetriani C; Giorgio M; Pandolfi P P; Cesareni G; Pelicci P G
A family of Shc related proteins with conserved PTB, CH1 and SH2 regions.
Oncogene 1996;13(3):633-41.
1995: Pandolfi P P; Sonati F; Rivi R; Mason P; Grosveld F; Luzzatto L
Targeted disruption of the housekeeping gene encoding glucose 6-phosphate dehydrogenase (G6PD): G6PD is dispensable for pentose synthesis but essential for defense against oxidative stress.
The EMBO journal 1995;14(21):5209-15.
1995: Maher J; Pandolfi P P; Roberts I A
Selection of a highly enriched population of retrovirus-infected human hematopoietic progenitor cells using SNL fibroblasts.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1995;9 Suppl 1():S29-33.
1995: Pandolfi P P; Roth M E; Karis A; Leonard M W; Dzierzak E; Grosveld F G; Engel J D; Lindenbaum M H
Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis.
Nature genetics 1995;11(1):40-4.
1995: Lavau C; Marchio A; Fagioli M; Jansen J; Falini B; Lebon P; Grosveld F; Pandolfi P P; Pelicci P G; Dejean A
The acute promyelocytic leukaemia-associated PML gene is induced by interferon.
Oncogene 1995;11(5):871-6.
1994: Diverio D; Pandolfi P P; Rossi V; Biondi A; Pelicci P G; Lo Coco F
Monitoring of treatment outcome in acute promyelocytic leukemia by RT-PCR.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(7):1105-7.
1994: Grignani F; Fagioli M; Alcalay M; Longo L; Pandolfi P P; Donti E; Biondi A; Lo Coco F; Grignani F; Pelicci P G
Acute promyelocytic leukemia: from genetics to treatment.
Blood 1994;83(1):10-25.
1994: Diverio D; Pandolfi P P; Rossi V; Biondi A; Pelicci P G; Lo Coco F
Monitoring of treatment outcome in acute promyelocytic leukemia by RT-PCR.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8 Suppl 2():S63-5.
1993: Diverio D; Pandolfi P P; Biondi A; Avvisati G; Petti M C; Mandelli F; Pelicci G; Lo Coco F
Absence of reverse transcription-polymerase chain reaction detectable residual disease in patients with acute promyelocytic leukemia in long-term remission.
Blood 1993;82(12):3556-9.
1993: Gambacorti-Passerini C; Grignani F; Arienti F; Pandolfi P P; Pelicci P G; Parmiani G
Human CD4 lymphocytes specifically recognize a peptide representing the fusion region of the hybrid protein pml/RAR alpha present in acute promyelocytic leukemia cells.
Blood 1993;81(5):1369-75.
1993: Biondi A; Rambaldi A; Pandolfi P P; Alcalay M; Longo L; Rossi V; Giudici G; Lo Coco F; Pelicci P G
Molecular genetics of the t(15;17) translocation in acute promyelocytic leukemia.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;131():345-59.
1992: Lo Coco F; Diverio D; Pandolfi P P; Biondi A; Rossi V; Avvisati G; Rambaldi A; Arcese W; Petti M C; Meloni G
Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukaemia.
Lancet 1992;340(8833):1437-8.
1992: Biondi A; Rambaldi A; Pandolfi P P; Rossi V; Giudici G; Alcalay M; Lo Coco F; Diverio D; Pogliani E M; Lanzi E M
Molecular monitoring of the myl/retinoic acid receptor-alpha fusion gene in acute promyelocytic leukemia by polymerase chain reaction.
Blood 1992;80(2):492-7.
1992: Fagioli M; Alcalay M; Pandolfi P P; Venturini L; Mencarelli A; Simeone A; Acampora D; Grignani F; Pelicci P G
Alternative splicing of PML transcripts predicts coexpression of several carboxy-terminally different protein isoforms.
Oncogene 1992;7(6):1083-91.
1992: Alcalay M; Zangrilli D; Fagioli M; Pandolfi P P; Mencarelli A; Lo Coco F; Biondi A; Grignani F; Pelicci P G
Expression pattern of the RAR alpha-PML fusion gene in acute promyelocytic leukemia.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(11):4840-4.
1992: Lanfrancone L; Pengue G; Pandolfi P P; Salcini A E; Giacomucci A; Longo L; Donti E; De Luca P; La Mantia G; Pelicci P G
Structural and functional organization of the HF.10 human zinc finger gene (ZNF35) located on chromosome 3p21-p22.
Genomics 1992;12(4):720-8.
1992: Pandolfi P P; Alcalay M; Fagioli M; Zangrilli D; Mencarelli A; Diverio D; Biondi A; Lo Coco F; Rambaldi A; Grignani F
Genomic variability and alternative splicing generate multiple PML/RAR alpha transcripts that encode aberrant PML proteins and PML/RAR alpha isoforms in acute promyelocytic leukaemia.
The EMBO journal 1992;11(4):1397-407.
1992: Lo Coco F; Diverio D; D'Adamo F; Avvisati G; Alimena G; Nanni M; Alcalay M; Pandolfi P P; Pelicci P G
PML/RAR-alpha rearrangement in acute promyelocytic leukaemias apparently lacking the t(15;17) translocation.
European journal of haematology 1992;48(3):173-6.
1992: Pandolfi P P; Alcalay M; Longo L; Fagioli M; Zangrilli D; Grignani F; Menccarelli A; Biondi A; Rambaldi A; LoCoco F
Molecular genetics of the t(15;17) of acute promyelocytic leukemia (APPL).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1992;6 Suppl 3():120S-122S.
1991: Lo Coco F; Avvisati G; Diverio D; Biondi A; Pandolfi P P; Alcalay M; De Rossi G; Petti M C; Cantù-Rajnoldi A; Pasqualetti D
Rearrangements of the RAR-alpha gene in acute promyelocytic leukaemia: correlations with morphology and immunophenotype.
British journal of haematology 1991;78(4):494-9.
1991: Pandolfi P P; Grignani F; Alcalay M; Mencarelli A; Biondi A; LoCoco F; Grignani F; Pelicci P G
Structure and origin of the acute promyelocytic leukemia myl/RAR alpha cDNA and characterization of its retinoid-binding and transactivation properties.
Oncogene 1991;6(7):1285-92.
1991: Lo Coco F; Avvisati G; Diverio D; Petti M C; Alcalay M; Pandolfi P P; Zangrilli D; Biondi A; Rambaldi A; Moleti M L
Molecular evaluation of response to all-trans-retinoic acid therapy in patients with acute promyelocytic leukemia.
Blood 1991;77(8):1657-9.
1991: Biondi A; Rambaldi A; Alcalay M; Pandolfi P P; Lo Coco F; Diverio D; Rossi V; Mencarelli A; Longo L; Zangrilli D
RAR-alpha gene rearrangements as a genetic marker for diagnosis and monitoring in acute promyelocytic leukemia.
Blood 1991;77(7):1418-22.
1991: Alcalay M; Zangrilli D; Pandolfi P P; Longo L; Mencarelli A; Giacomucci A; Rocchi M; Biondi A; Rambaldi A; Lo Coco F
Translocation breakpoint of acute promyelocytic leukemia lies within the retinoic acid receptor alpha locus.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(5):1977-81.
1990: Longo L; Pandolfi P P; Biondi A; Rambaldi A; Mencarelli A; Lo Coco F; Diverio D; Pegoraro L; Avanzi G; Tabilio A
Rearrangements and aberrant expression of the retinoic acid receptor alpha gene in acute promyelocytic leukemias.
The Journal of experimental medicine 1990;172(6):1571-5.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Pier Paolo Pandolfi

Research Profile (preview)

Living Beings

Chemicals & Drugs

Disorders

Physiology

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Pier Paolo Pandolfi (preview)

All Publications